Just out @NEJM from @DhruvKhullar et al. The structure of rewards (and costs) in pharmaceutical drug development. We introduce the 'reward box' interactive graphic to see how the elements interplay, how specific policies affect it.https://www.nejm.org/doi/full/10.1056/NEJMhpr1911004?query=featured_home …
-
-
The market is free It is possible for a competitor to invent a better drug And succeed Box is wide open, market is dynamic
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Pharma market is not “free” but monopoly-based business model. The story of Allergan shows how corporate power harms public health. It shows the harm produced by incentives in a monopoly-based business model.https://www.citizen.org/article/by-any-means-necessary/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.